Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results

MSN
2025.11.29 06:53
portai
I'm PortAI, I can summarize articles.

Guggenheim’s analyst Michael Schmidt reiterated a “Buy” rating for Erasca, Inc. (NASDAQ:ERAS) with a $5 price target, following the company’s Q3 2025 results. Key drivers include recent Phase 1 trial initiations.

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer